The status and the expression of cyclin-dependent kinase inhibitor A (CDKN2A) family genes, named CDKN2A, CDKN2B, and CDKN2C and of cyclin Ds (D1, D2, and D3) genes were investigated in 14 cases of human hepatoblastomas. These genes were selected because: 1) CDKN2A and CDKN2B are very frequently ina
Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
✍ Scribed by Flores, José F; Pollock, Pamela M; Walker, Graeme J; Glendening, J Michael; Lin, Amy H-T; Palmer, Jane M; Walters, Marilyn K; Hayward, Nicholas K; Fountain, Jane W
- Book ID
- 110061043
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 350 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
p I 6"K4A, p I 5"K4B, and p i 8 proteins are highly specific inhibitors of cyclin-dependent serindthreonine kinase (CDK) activities required for G IS transition in the eukaryotic cell division cycle. Mutations, mainly homozygous deletions, of the CDKN2A (p16"K4A/MTSI) gene have been recently found i
## Abstract Approximately 50% of all melanoma families worldwide show linkage to 9p21‐22, but only about half of these have been shown to contain germ line __CDKN2A__ mutations. It has been hypothesized that a proportion of these families carry mutations in the noncoding regions of __CDKN2A.__ Seve
The p16/CDKN2 (MTS1) gene encoding for the p16 inhibitor of cyclin D/CDK4 complexes is frequently mutated and deleted in a large fraction of melanoma cell lines, and p16 germline mutations have also been observed in familial melanomas. Moreover, a CDK4 gene mutation, responsible for a functional res